Skip to main content
SpringerLink
Log in

Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit

  • Research Letter
  • Published:
Applied Health Economics and Health Policy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Table I

References

  1. Public health in Switzerland. Distribution of health care costs by prestations in 2007. [online]. Available from URL: http://www.interpharma.ch/fr/faites-et-statistiques/Sante-publique-en-Suisse.asp [Accessed 2012 Feb 27]

  2. Maarse H, Rooijakkers D, Duzijn R. Institutional responses to Medicare’s prospective payment system. Health Policy 1993; 25: 255–70

    Article  PubMed  CAS  Google Scholar 

  3. Anatomical Therapeutic Chemical (ATC) classification index. Geneva: WHO Collaborating Centre for Drug Statistics Methodology, 2012 [online]. Available from URL: http://www.whocc.no/atc_ddd_index [Accessed 2012 Feb 27]

  4. Conti G, Dell’Utri D, Pelaia P, et al. Do we know what we prescribe? A study of awareness of the cost of drugs and devices among ICU staff. Intens Care Med 1998; 24: 1194–8

    Article  CAS  Google Scholar 

  5. Weber RJ, Kane SL, Oriolo VA, et al. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003; 31 Suppl. 1: S17–24

    Article  PubMed  Google Scholar 

  6. Mascia MF, Koch M, Medicis J. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med 2000; 20: 2300–6

    Article  Google Scholar 

  7. Cox CE, Reed SD, Govert JA, et al. Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med 2008; 36: 706–14

    Article  PubMed  Google Scholar 

  8. Zilberberg MD, Kothari S, Shorr AF. Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation. Crit Care 2009; 13(3): R94

    Article  PubMed  Google Scholar 

  9. Reboli AC, Rotstein C, Kett DH, et al. Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients. Pharmacoeconomics 2011; 29: 705–17

    Article  PubMed  Google Scholar 

  10. Amaral AC, Rubenfeld GD. The future of critical care. Curr Opin Crit Care 2009; 15: 308–13

    Article  PubMed  Google Scholar 

  11. MacLaren R, Bond CA, Martin SJ. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 2008; 36: 3269–70

    Article  Google Scholar 

  12. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008; 36: 427–33

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the contribution of Carole Matzinger for providing the database.

No sources of funding were used to conduct this study. The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. Institute of Health Economics and Management, University of Lausanne, Lausanne, Switzerland

    Christine Carron &  Jean-Blaise Wasserfallen (Medical Direction)

  2. Service of Pharmacy, Lausanne University Hospital (CHUV), Lausanne, Switzerland

    Pierre Voirol & André Pannatier

  3. Service of Adult Intensive Care, Lausanne University Hospital (CHUV), Lausanne, Switzerland

    Philippe Eggimann & René Chioléro

Authors
  1. Christine Carron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Voirol
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Eggimann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. André Pannatier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. René Chioléro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean-Blaise Wasserfallen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Blaise Wasserfallen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carron, C., Voirol, P., Eggimann, P. et al. Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit. Appl Health Econ Health Policy 10, 355–358 (2012). https://doi.org/10.1007/BF03261869

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03261869

Keywords

Search

Navigation